Nektar Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NKTR and buy or sell other stocks, ETFs, and their options commission-free!

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. 

CEO
Howard W. Robin
CEOHoward W. Robin
Employees
61
Employees61
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1990
Founded1990
Employees
61
Employees61

NKTR Key Statistics

Market cap
1.88B
Market cap1.88B
Price-Earnings ratio
-15.73
Price-Earnings ratio-15.73
Dividend yield
—
Dividend yield—
Average volume
1.99M
Average volume1.99M
High today
$10.41
High today$10.41
Low today
$9.83
Low today$9.83
Open price
$0.6866
Open price$0.6866
Volume
0.00
Volume0.00
52 Week high
$10.41
52 Week high$10.41
52 Week low
$0.432
52 Week low$0.432
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.